Reciprocal modulation of mitogen-activated protein kinases and mitogen-activated protein kinase phosphatase 1 and 2 in failing human myocardium.

BACKGROUND Mitogen-activated protein kinases (MAPKs), consisting of the ERK1/2, JNKs, and p38-kinase families, play a key role in the regulation of myocyte growth and apoptosis in vitro. The activity of MAPKs is regulated by dual-specificity MAPK phosphatases (MKPs). Because myocardial failure is associated with myocyte hypertrophy and apoptosis, MAPKs may play a pathophysiologic role in human myocardial failure. METHODS AND RESULTS We measured MAPKs activities and the protein levels of MAPKs and MKPs (MKP-1 and MKP-2) in the myocardium explanted at the time of transplantation from patients with end-stage failure caused by idiopathic dilated cardiomyopathy (n = 5-7). Nonfailing donor hearts (n = 5-7) were used for comparison. Although the protein levels for JNK1/2 and p38-kinase in failing hearts were not different from levels in nonfailing hearts, the activities of both were decreased (P <.05). Despite a >3-fold increase in the protein level for ERK1/2 in failing hearts, ERK1/2 activity was not increased. Expression of MKP-2 was significantly increased in failing hearts, while expression of MKP-1 was increased in 5 of 7 failing hearts as measured by Western analysis. CONCLUSIONS JNK1/2 and p38 activities are decreased in failing human myocardium. Increased expression of MKPs may therefore contribute to decreased MAPKs activity in failing human myocardium.

[1]  D. Mann,et al.  Differential Regulation of Mitogen-Activated Protein Kinases in the Failing Human Heart in Response to Mechanical Unloading , 2001, Circulation.

[2]  G. Sandusky,et al.  Decreased p38 MAPK activity in end-stage failing human myocardium: p38 MAPK alpha is the predominant isoform expressed in human heart. , 2001, Journal of molecular and cellular cardiology.

[3]  W. Hayashida,et al.  Alterations of load-induced p38 MAP kinase activation in failing rat hearts. , 2001, Biochemical and biophysical research communications.

[4]  Jiahuai Han,et al.  Calcineurin Enhances MAPK Phosphatase-1 Expression and p38 MAPK Inactivation in Cardiac Myocytes* , 2001, The Journal of Biological Chemistry.

[5]  Y. Kihara,et al.  Stage-specific differential activation of mitogen-activated protein kinases in hypertrophied and failing rat hearts. , 2001, Journal of molecular and cellular cardiology.

[6]  R. Hajjar,et al.  Differential Activation of Signal Transduction Pathways in Human Hearts With Hypertrophy Versus Advanced Heart Failure , 2001, Circulation.

[7]  J. Molkentin,et al.  The Dual-Specificity Phosphatase MKP-1 Limits the Cardiac Hypertrophic Response In Vitro and In Vivo , 2001, Circulation research.

[8]  W. Colucci,et al.  p38 Mitogen-activated Protein Kinase Pathway Protects Adult Rat Ventricular Myocytes against β-Adrenergic Receptor-stimulated Apoptosis , 2000, The Journal of Biological Chemistry.

[9]  Activation of c-Jun N-terminal kinases and p38-mitogen-activated protein kinases in human heart failure secondary to ischaemic heart disease. , 1999, Journal of molecular and cellular cardiology.

[10]  Yan-Lin Guo,et al.  Resistance to TNF-α cytotoxicity can be achieved through different signaling pathways in rat mesangial cells. , 1999, American journal of physiology. Cell physiology.

[11]  T. Sugimoto,et al.  Mitogen-activated protein kinase phosphatase: a negative regulator of the mitogen-activated protein kinase cascade. , 1999, European journal of pharmacology.

[12]  R. Hajjar,et al.  Signaling pathways mediating the response to hypertrophic stress in the heart. , 1999, Gene expression.

[13]  M. Lindemann,et al.  Regulation of mitogen-activated protein kinase phosphatase-1 in vascular smooth muscle cells. , 1998, Hypertension.

[14]  F. Xia,et al.  Oxidative stress induces DNA fragmentation and caspase activation via the c-Jun NH2-terminal kinase pathway in H9c2 cardiac muscle cells. , 1998, Journal of molecular and cellular cardiology.

[15]  D. Kaye,et al.  Role of AT1 and AT2 receptors in regulation of MAPKs and MKP-1 by ANG II in adult cardiac myocytes. , 1998, The American journal of physiology.

[16]  A. Clerk,et al.  "Stress-responsive" mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium. , 1998, Circulation research.

[17]  D. Zechner,et al.  MKK6 Activates Myocardial Cell NF-κB and Inhibits Apoptosis in a p38 Mitogen-activated Protein Kinase-dependent Manner* , 1998, The Journal of Biological Chemistry.

[18]  Jiahuai Han,et al.  Cardiac Hypertrophy Induced by Mitogen-activated Protein Kinase Kinase 7, a Specific Activator for c-Jun NH2-terminal Kinase in Ventricular Muscle Cells* , 1998, The Journal of Biological Chemistry.

[19]  J Ross,et al.  Cardiac Muscle Cell Hypertrophy and Apoptosis Induced by Distinct Members of the p38 Mitogen-activated Protein Kinase Family* , 1998, The Journal of Biological Chemistry.

[20]  J. Bonventre,et al.  Growth factors and mitogen-activated protein kinases. , 1998, Hypertension.

[21]  T. Hunter,et al.  p38-2, a Novel Mitogen-activated Protein Kinase with Distinct Properties* , 1997, The Journal of Biological Chemistry.

[22]  A. Kraft,et al.  Conditional Expression of the Mitogen-activated Protein Kinase (MAPK) Phosphatase MKP-1 Preferentially Inhibits p38 MAPK and Stress-activated Protein Kinase in U937 Cells* , 1997, The Journal of Biological Chemistry.

[23]  N. Tonks,et al.  Mitogen-activated protein kinase phosphatase 1 inhibits the stimulation of gene expression by hypertrophic agonists in cardiac myocytes. , 1997, The Biochemical journal.

[24]  K. Chien,et al.  Cardiotrophin 1 (CT-1) Inhibition of Cardiac Myocyte Apoptosis via a Mitogen-activated Protein Kinase-dependent Pathway , 1997, The Journal of Biological Chemistry.

[25]  W. Schmitz,et al.  Increased expression of cardiac phosphatases in patients with end-stage heart failure. , 1997, Journal of molecular and cellular cardiology.

[26]  Wei Guo,et al.  Characterization of the Structure and Function of a New Mitogen-activated Protein Kinase (p38β)* , 1996, The Journal of Biological Chemistry.

[27]  B. Berk,et al.  Differential activation of mitogen-activated protein kinases by H2O2 and O2- in vascular smooth muscle cells. , 1995, Circulation research.

[28]  H. Yao,et al.  A Novel Mitogen-activated Protein Kinase Phosphatase. STRUCTURE, EXPRESSION, AND REGULATION (*) , 1995, The Journal of Biological Chemistry.